Cell-based Assays: Technologies and Global Markets

Report Highlights

Cell biology is currently the biggest revenue contributor to the life-science tools industry, accounting for approximately 30% of total sales.  It is expected to grow to a $15 billion market by 2015, increasing at a compound annual growth rate (CAGR) of 12.3% from its 2010 value of $8.5 billion.

Report Scope

The proposed report will give an update on Cell-Based Assays:  Technologies and Global Markets.  It will review global markets for cell-based assays and new developments and will forecast trends for use of these assays for drug discovery and safety and toxicology through 2015.  Important assays, technologies and latest developments, market share by assay type, products on the market and market share by company, and statistical information for types of cancers prevalent worldwide, with special emphasis on the U.S. market.  The report also includes current issues and trends affecting the industry and costs, and factors influencing demand will be discussed.  The report covers products in development, new technologies, trends, alliances, and mergers.  The report offers market data with respect to segments and geography.  It also provides market trends with respect to drivers, restraints, and opportunities.

Analyst Credentials

Usha Nagavarapu is an experienced pharmaceutical professional with business development experience.  She has more than 10 years of preclinical, alliance management, discovery, and technology development and marketing experience.  Her strong focus areas include oncology and cardiovascular diseases, with expertise in molecular and cell biology and complex cell-based biological assays ranging from drug discovery, in vitro and in vivo screening, in vivo model development, and pharmacokinetics.  She has experience working with early start-ups.